Tarsus Pharmaceuticals, Inc. TARS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.97M+16.8% | -$8.37M+33.5% | -$12.59M+38.1% | -$20.34M+19.0% | -$25.12M-8.7% | ||
| $197K-2.5% | $202K+1.0% | $200K0.0% | $200K-9.1% | $220K+14.6% | ||
| $11.97M-16.4% | $14.31M+16.9% | $12.24M+48.7% | $8.23M+18.8% | $6.93M-6.4% | ||
| -$24.65M— | —— | —— | -$29.39M-42.3% | -$20.65M+6.9% | ||
| $5.82M-8.5% | $6.36M+233% | $1.91M+90.8% | $1M+69.7% | $590K+719% | ||
| -$58.56M— | —— | -$4.74M+90.8% | -$51.7M-48.0% | -$34.94M+41.3% | ||
| $1.2M-47.9% | $2.31M-9.8% | $2.56M+31.3% | $1.95M-98.6% | $136.56M+4,566% | ||
| -$82.01M-216% | $70.92M+341% | $16.08M— | —— | $80.97M+203% | ||
| -$30.47M— | —— | —— | -$30.39M-43.1% | -$21.24M+4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tarsus Pharmaceuticals, Inc. generate?
- Tarsus Pharmaceuticals, Inc. (TARS) generated -$96.9M in operating cash flow over the trailing twelve months.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow?
- After $15.1M of capital expenditures, Tarsus Pharmaceuticals, Inc.'s free cash flow was -$104.4M over the trailing twelve months, down 2.6% year over year.
- Where does Tarsus Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
